Back to results
US 10,377,742 B2Granted
AMPK-activating heterocyclic compounds and methods for using the same
AssigneeRigel Pharmaceuticals, Inc.
InventorsDane Goff, Donald Payan, Rajinder Singh, Simon Shaw, David Carroll, Yasumichi Hitoshi
Life of this patent
Estimating the term…
Abstract
Disclosed are substituted pyridine compounds as well as pharmaceutical compositions and methods of use. One embodiment is a compound having the structure wherein E, J, T, the ring system denoted by “B”, T, R3, R4, w and x are as described herein. In certain embodiments, a compound disclosed herein activates the AMPK pathway, and can be used to treat metabolism-related disorders and conditions.
Claims21
A compound having the structural formula:
- or a pharmaceutically acceptable salt or N-oxide thereof, wherein
- one of X1 and X2 is N, and the others are CH or C substituted by one of the w R3;
- Y is N or CH;
- R1 is H;
- G is —CH2—, —C(O)— or S(O)2—;
- R17 is phenyl substituted with 0, 1 or 2 substituents each independently selected from methyl, ethyl, n-propyl, isopropyl, trifluoromethyl, pentafluoroethyl, acetyl, —NH2, —OH, methoxy, ethoxy, trifluoromethoxy, —SO2Me, -halogen, —NO2, N3, —SF5, and —CN;
- w is 0, 1 or 2;
- each R3 is independently selected from methyl, ethyl, n-propyl, isopropyl, trifluoromethyl, pentafluoroethyl, acetyl, —NH2, —OH, methoxy, ethoxy, trifluoromethoxy, —SO2Me, -halogen, —NO2 and —CN;
- Q is a single bond, —CH2—, —O—, —C(O)— or —S(O)2—;
- the ring system denoted by “A” is phenyl;
- each R5 is independently selected from methyl, trifluoromethyl, acetyl, methoxy, trifluoromethoxy, -halogen, —NO2, N3, —SF5, and —CN;
- and
- y is 0, 1 or 2.
10 more elements
Dependencies are inferred from the claim text.